Materab-L Capsule SR
(LEVOSULPIRIDE + RABEPRAZOLE)
Can I drive while taking Gerdrid L?
The consumption of Gerdrid L can potentially cause drowsiness dizziness or even affect your vision Due to these possible side effects it is strongly advised to avoid operating vehicles or machinery until you fully understand how this medication may affect your body Your safety should be a top priority so it is crucial to exercise caution and take necessary precautions while taking Gerdrid L It is important to be aware of the potential impact this medication can have on your ability to perform certain tasks that require focus and alertness By refraining from activities that require intense concentration you can minimize the risk of any accidents or injuries that may occur as a result of these side effects Therefore it is highly recommended to take proper measures and prioritize safety when using Gerdrid L
What are the instructions for the storage and disposal of Materab-L?
Keep this medicine in the packet or the container it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.
Can I drive while taking Materab-L?
No, taking Materab-L may make you feel sleepy, dizzy or could affect your eyesight. So do not drive or use machines until you know how this medicine affects you.
Does the use of Materab-L lead to increased risk of fractures?
Several studies in adults suggest that treatment with Materab-L may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist or spine. The risk of fracture was increased in patients who received high dose. High dose can mean multiple daily doses, and long-term therapy (a year or longer).
Can I drive while taking Materab-L?
No, taking Materab-L may make you feel sleepy, dizzy or could affect your eyesight. So do not drive or use machines until you know how this medicine affects you.
Does the use of Materab-L lead to increased risk of fractures?
Several studies in adults suggest that treatment with Materab-L may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist or spine. The risk of fracture was increased in patients who received high dose. High dose can mean multiple daily doses, and long-term therapy (a year or longer).
Similar Medicines
Levosulpiride (75mg) + Rabeprazole (20mg)
Levosulpiride (75mg) + Rabeprazole (20mg)
Levosulpiride (75mg) + Rabeprazole (20mg)
Levosulpiride (75mg) + Rabeprazole (20mg)
Levosulpiride (75mg) + Rabeprazole (20mg)
Levosulpiride (75mg) + Rabeprazole (20mg)
Levosulpiride (75mg) + Rabeprazole (20mg)
Levosulpiride (75mg) + Rabeprazole (20mg)
Levosulpiride (75mg) + Rabeprazole (20mg)
Levosulpiride (75mg) + Rabeprazole (20mg)
.svg)
